tiprankstipranks
PAUL HARTMANN AG (DE:PHH2)
FRANKFURT:PHH2
Germany Market
Holding DE:PHH2?
Track your performance easily

PAUL HARTMANN AG (PHH2) Stock Price & Analysis

1 Followers

PHH2 Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%100.00%
― Other Institutional Investors
100.00% Public Companies and
Individual Investors

PHH2 FAQ

What was PAUL HARTMANN AG’s price range in the past 12 months?
PAUL HARTMANN AG lowest stock price was €183.00 and its highest was €244.00 in the past 12 months.
    What is PAUL HARTMANN AG’s market cap?
    Currently, no data Available
    When is PAUL HARTMANN AG’s upcoming earnings report date?
    PAUL HARTMANN AG’s upcoming earnings report date is Mar 20, 2025 which is in 117 days.
      How were PAUL HARTMANN AG’s earnings last quarter?
      PAUL HARTMANN AG released its earnings results on Mar 19, 2024. The company reported €4.711 earnings per share for the quarter, beating the consensus estimate of N/A by €4.711.
        Is PAUL HARTMANN AG overvalued?
        According to Wall Street analysts PAUL HARTMANN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does PAUL HARTMANN AG pay dividends?
          PAUL HARTMANN AG pays a Annually dividend of €8 which represents an annual dividend yield of 3.77%. See more information on PAUL HARTMANN AG dividends here
            What is PAUL HARTMANN AG’s EPS estimate?
            PAUL HARTMANN AG’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does PAUL HARTMANN AG have?
            PAUL HARTMANN AG has 3,572,424 shares outstanding.
              What happened to PAUL HARTMANN AG’s price movement after its last earnings report?
              PAUL HARTMANN AG reported an EPS of €4.711 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.92%.
                Which hedge fund is a major shareholder of PAUL HARTMANN AG?
                Currently, no hedge funds are holding shares in DE:PHH2
                ---

                PAUL HARTMANN AG Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                9.63%
                12-Months-Change

                Fundamentals

                Return on Equity
                5.58%
                Trailing 12-Months
                Asset Growth
                2.38%
                Trailing 12-Months

                Company Description

                PAUL HARTMANN AG

                Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Knorr-Bremse AG
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis